Halent Zhang's practice focuses on corporate finance and commercial transactions. She has extensive experience advising clients on initial public offerings (IPOs), public and private M&As, cross-border investments, joint ventures, placings, open offers, block trades, bond issues, and other general corporate and commercial matters. She also assists listed companies in their day-to-day legal regulatory and compliance matters.
Halent's highlighted transactions include advising: underwriters on the US$1.7 billion initial public offering of China Zheshang Bank; Shanghai Junshi Biosciences on its HK$450 million initial public offering; Foxconn on its HK$460 million takeover of a Hong Kong-listed IT company; and AGIC Capital in its US$1.2 billion fund formation and downstream investments.
Prior to joining Jones Day in 2015, Halent represented a listed company in its HK$2 billion acquisition of a dedicated oolong tea producer and advised a listed company on its issue of RMB491 million convertible bonds.
Consultation Conclusions on Proposed Amendments to Enforcement-Related Provisions of Hong Kong's SFO
Consultation Paper on the Hong Kong Securities and Futures Commission's Proposed Amendments to the Takeovers Codes
- City University of Hong Kong (P.C.LL. 2010; J.D. 2009); East China University of Science and Technology (B.Eng. 2007)
- Hong Kong
- Mandarin, English, and Cantonese